Ethic Inc. United Therapeutics Corp Transaction History

Ethic Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $73,918 - $88,387	344 Added 33.24%	1,379 $303,000
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $219,233 - $256,928	1,035 New	1,035 $233,000
Q2 2022 Aug 10, 2022	SELL	$174.81 - $241.14 $432,130 - $596,098	-2,472 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $410,747 - $528,909	2,472 New	2,472 $444,000

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

Stay updated on Ethic Inc. with notifications on news.